Decibel Cannabis Company Inc.
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Decibel Cannabis Company Inc. (DBCCF) operates as an integrated cannabis company focused on cultivation, extraction, processing, manufacturing, and sales of premium recreational and medical cannabis products in Canada and select international markets. The company offers craft cannabis flowers, vape cartridges, cannabis-infused pre-rolls, edibles, and other value-added formats under its core brands Qwest, Vox, Blendcraft, Prairie Records, and General Admission; it also provides business-to-business wholesale sales in Saskatchewan and Alberta, alongside e-commerce and retail operations targeting end-user consumers in Saskatchewan. Founded in 2017 and headquartered in Calgary, Alberta, Decibel maintains three cultivation facilities including the Qwest Estate in Creston, British Columbia, and Thunderchild Cultivation, plus a processing and manufacturing center, with products distributed across Canadian provinces and expanding into global markets such as Australia, Israel, Denmark, Germany, Norway, Spain, and the United Kingdom. In late 2024, Decibel completed the acquisition of AgMedica Bioscience Ltd. and GreenSeal Nursery Ltd., adding an EU-GMP-certified facility in Chatham, Ontario, that enhances export capabilities with 5.1 metric tonnes of annual flower production and supports projected 2025 revenue contributions of $30 million; this transaction, approved by the TSX Venture Exchange in December 2024, marks the initiation of a strategy emphasizing synergistic acquisitions for profitable international growth. Additionally, in early 2025, Decibel entered a supply and trademark license agreement with Keren Tirk Ltd. to distribute General Admission branded medical cannabis flower in Israel, with initial shipments anticipated in Q2 2025, complementing prior launches like General Admission vapes in Australia's medicinal market.
Company News
Decibel Announces Commencement of Trading Following its 15:1 Share Consolidation
Decibel Reports Second Quarter 2026 Results: Revenue Grows 19% YoY to Record $36 Million, Raises Full Year Outlook, Announces 15:1 Share Consolidation and Anticipated Normal Course Issuer Bid
Decibel to Announce Second Quarter 2026 Financial Results on August 20, 2026
Decibel Reports First Quarter 2026 Results: Quarterly Revenue Grows 41% YoY to $30 Million, Issues Q2 2026 Guidance
Decibel to Announce First Quarter 2026 Financial Results on May 21, 2026
Decibel Reports Full-Year and Fourth Quarter 2025 Results: Revenue Grows 22% to $113 Million, Issues 2026 Guidance
Decibel to Announce Fourth Quarter 2025 Financial Results on April 16, 2026
Decibel Announces Sale of Creston Property and Consolidation of Cultivation Facilities
Decibel Announces Stock Option Grants
Decibel Announces Closing of $61 Million Credit Facility with ATB Financial
Decibel Announces Results of Annual and Special Meeting of Shareholders
Decibel Reports Third Quarter 2025 Financial Results
Decibel to Announce Third Quarter 2025 Financial Results on November 19, 2025
Decibel Delivers Strong Revenue Growth and Profitability in Second Quarter
Decibel Announces First Quarter Results
Decibel Announces Year End and Fourth Quarter Results, 2025 Guidance
Decibel Expands General Admission Brand's International Footprint
Decibel Expands General Admission Vape Position
Decibel Announces Stock Option Grants
Decibel Announces Third Quarter Results